POST Online Media Lite Edition


Paul J. Clancy joins Agios board of directors

Staff writer |
Cambridge, Mass., USA - September 26, 2013, Cambridge, Mass., USA - Agios Pharmaceuticals, Inc. announced the addition of Paul J. Clancy, executive vice president and chief financial officer at Biogen Idec, to the company’s board of directors.

Mr. Clancy has more than 20 years of experience in financial management and strategic business planning. Mr. Clancy has served as the executive vice president and chief financial officer at Biogen Idec since August 2007. He also served as senior vice president of finance, with responsibilities for leading the treasury, tax, investor relations and business planning groups.

Prior to the merger of Biogen and Idec, Mr. Clancy was the vice president of portfolio management at Biogen Inc. He joined the company in 2001 as vice president of U.S. marketing. Before Biogen Inc., Mr. Clancy spent 13 years at PepsiCo, serving in a variety of financial and general management positions, including vice president and general manager of their Great West Business Unit.

LATEST 5 MOVES FROM Massachusetts 

What to read next

Azuki Systems: John Clancy new president and chief executive officer
Mike Clancy COO Markel Claims
Editas Medicine appoints Andrew Hirsch to board